PMDA — authorised 26 March 2015
- Marketing authorisation holder: Eli Lilly Japan K.K.
- Status: approved
🇯🇵 Cyramza in Japan
PMDA authorised Cyramza on 26 March 2015
Marketing authorisation
Cyramza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Cyramza approved in Japan?
Yes. PMDA authorised it on 26 March 2015.
Who is the marketing authorisation holder for Cyramza in Japan?
Eli Lilly Japan K.K. holds the Japanese marketing authorisation.